PSA testing for prostate cancer: Understanding the debate

PSA testing for prostate cancer is controversial due to its potential for false positives and inability to distinguish between life-threatening and non-threatening cancers. Experts like Dr. Christopher Warlick highlight that elevated PSA levels can result from noncancerous conditions, and the United States Preventive Services Task Force recommends men aged 55-69 discuss screening with their providers, particularly those at higher risk such as African American men or those with family histories of prostate cancer.